title: Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing.
abstract: Increasing rates of HIV testing within substance use disorder (SUD) treatment clients is an important public health strategy for reducing HIV transmission rates. The present study examined uptake of HIV testing among 1,224 clients in five SUD treatment units that offered on-site testing in Florida, New York, and California. Nearly one-third (30 %) of the participants, who had not previously tested positive, reported not having been tested for HIV within the past 12 months. Women, African Americans, and injection drug users had a higher likelihood of having been tested within the past 12 months. The SUD treatment program was the most frequently identified location of participants' last HIV test. Despite the availability of free, on-site testing, a substantial proportion of clients were not tested, suggesting that strategies to increase uptake of testing should include addressing barriers not limited to location and cost.
authors: Aspire Health Partners, 5151 Adanson Street, Orlando, FL, 32804, USA, tiffany.kyle@aspirehp.org.
authors: Tiffany L
authors: TL
authors: Kyle
authors: Viviana E
authors: VE
authors: Horigian
authors: Susan
authors: S
authors: Tross
authors: Valerie A
authors: VA
authors: Gruber
authors: Margaret
authors: M
authors: Pereyra
authors: Raul N
authors: RN
authors: Mandler
authors: Daniel J
authors: DJ
authors: Feaster
authors: Lisa R
authors: LR
authors: Metsch
mesh_terms: D015492:AIDS Serodiagnosis / Q000706:statistics & numerical data*; D000328:Adult; D040343:Behavioral Risk Factor Surveillance System; D002140:California / Q000453:epidemiology; D003362:Cost-Benefit Analysis; D005260:Female; D005431:Florida / Q000453:epidemiology; D015658:HIV Infections / Q000175:diagnosis / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D009518:New York / Q000453:epidemiology; D015397:Program Evaluation; D011634:Public Health; D012309:Risk-Taking; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000453:epidemiology* / Q000523:psychology